Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based
homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine
antagonists binding site of the human adenosine A2A receptor
L. Michielan, M. Bacilieri, A. Schiesaro, C. Bolcato, G. Pastorin, G. Spalluto, B. Cacciari, K. Klotz, C. Kaseda, and S. Moro. J Chem Inf Model, 48 (2):
350-63(February 2008)Michielan, Lisa Bacilieri, Magdalena Schiesaro, Andrea Bolcato, Chiara
Pastorin, Giorgia Spalluto, Giampiero Cacciari, Barbara Klotz, Karl
Norbet Kaseda, Chosei Moro, Stefano Research Support, Non-U.S. Gov't
United States Journal of chemical information and modeling J Chem
Inf Model. 2008 Feb;48(2):350-63. Epub 2008 Jan 24..
Abstract
The integration of ligand- and structure-based strategies might sensitively
increase the success of drug discovery process. We have recently
described the application of Molecular Electrostatic Potential autocorrelated
vectors (autoMEPs) in generating both linear (Partial Least-Square,
PLS) and nonlinear (Response Surface Analysis, RSA) 3D-QSAR models
to quantitatively predict the binding affinity of human adenosine
A3 receptor antagonists. Moreover, we have also reported a novel
GPCR modeling approach, called Ligand-Based Homology Modeling (LBHM),
as a tool to simulate the conformational changes of the receptor
induced by ligand binding. In the present study, the application
of both linear and nonlinear 3D-QSAR methods and LBHM computational
techniques has been used to depict the hypothetical antagonist binding
site of the human adenosine A2A receptor. In particular, a collection
of 127 known human A2A antagonists has been utilized to derive two
3D-QSAR models (autoMEPs/PLS&RSA). In parallel, using a rhodopsin-driven
homology modeling approach, we have built a model of the human adenosine
A2A receptor. Finally, 3D-QSAR and LBHM strategies have been utilized
to predict the binding affinity of five new human A2A pyrazolo-triazolo-pyrimidine
antagonists finding a good agreement between the theoretical and
the experimental predictions.
Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based
homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine
antagonists binding site of the human adenosine A2A receptor
Michielan, Lisa Bacilieri, Magdalena Schiesaro, Andrea Bolcato, Chiara
Pastorin, Giorgia Spalluto, Giampiero Cacciari, Barbara Klotz, Karl
Norbet Kaseda, Chosei Moro, Stefano Research Support, Non-U.S. Gov't
United States Journal of chemical information and modeling J Chem
Inf Model. 2008 Feb;48(2):350-63. Epub 2008 Jan 24.
%0 Journal Article
%1 Michielan2008
%A Michielan, L.
%A Bacilieri, M.
%A Schiesaro, A.
%A Bolcato, C.
%A Pastorin, G.
%A Spalluto, G.
%A Cacciari, B.
%A Klotz, K. N.
%A Kaseda, C.
%A Moro, S.
%D 2008
%J J Chem Inf Model
%K & *Models, *Quantitative *Sequence A2A/antagonists Acid Adenosine Amino Binding Homology, Humans Ligands Molecular Pyrazoles Pyrimidines Relationship Sites Structure-Activity Triazoles inhibitors/*chemistry Receptor
%N 2
%P 350-63
%T Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based
homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine
antagonists binding site of the human adenosine A2A receptor
%U http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18215030
%V 48
%X The integration of ligand- and structure-based strategies might sensitively
increase the success of drug discovery process. We have recently
described the application of Molecular Electrostatic Potential autocorrelated
vectors (autoMEPs) in generating both linear (Partial Least-Square,
PLS) and nonlinear (Response Surface Analysis, RSA) 3D-QSAR models
to quantitatively predict the binding affinity of human adenosine
A3 receptor antagonists. Moreover, we have also reported a novel
GPCR modeling approach, called Ligand-Based Homology Modeling (LBHM),
as a tool to simulate the conformational changes of the receptor
induced by ligand binding. In the present study, the application
of both linear and nonlinear 3D-QSAR methods and LBHM computational
techniques has been used to depict the hypothetical antagonist binding
site of the human adenosine A2A receptor. In particular, a collection
of 127 known human A2A antagonists has been utilized to derive two
3D-QSAR models (autoMEPs/PLS&RSA). In parallel, using a rhodopsin-driven
homology modeling approach, we have built a model of the human adenosine
A2A receptor. Finally, 3D-QSAR and LBHM strategies have been utilized
to predict the binding affinity of five new human A2A pyrazolo-triazolo-pyrimidine
antagonists finding a good agreement between the theoretical and
the experimental predictions.
@article{Michielan2008,
abstract = {The integration of ligand- and structure-based strategies might sensitively
increase the success of drug discovery process. We have recently
described the application of Molecular Electrostatic Potential autocorrelated
vectors (autoMEPs) in generating both linear (Partial Least-Square,
PLS) and nonlinear (Response Surface Analysis, RSA) 3D-QSAR models
to quantitatively predict the binding affinity of human adenosine
A3 receptor antagonists. Moreover, we have also reported a novel
GPCR modeling approach, called Ligand-Based Homology Modeling (LBHM),
as a tool to simulate the conformational changes of the receptor
induced by ligand binding. In the present study, the application
of both linear and nonlinear 3D-QSAR methods and LBHM computational
techniques has been used to depict the hypothetical antagonist binding
site of the human adenosine A2A receptor. In particular, a collection
of 127 known human A2A antagonists has been utilized to derive two
3D-QSAR models (autoMEPs/PLS&RSA). In parallel, using a rhodopsin-driven
homology modeling approach, we have built a model of the human adenosine
A2A receptor. Finally, 3D-QSAR and LBHM strategies have been utilized
to predict the binding affinity of five new human A2A pyrazolo-triazolo-pyrimidine
antagonists finding a good agreement between the theoretical and
the experimental predictions.},
added-at = {2010-12-14T18:12:02.000+0100},
author = {Michielan, L. and Bacilieri, M. and Schiesaro, A. and Bolcato, C. and Pastorin, G. and Spalluto, G. and Cacciari, B. and Klotz, K. N. and Kaseda, C. and Moro, S.},
biburl = {https://www.bibsonomy.org/bibtex/2f064a29f6e54aaa8869a33ecc2b01940/pharmawuerz},
endnotereftype = {Journal Article},
interhash = {2e3864869a4335acb91d24dc0a1208fe},
intrahash = {f064a29f6e54aaa8869a33ecc2b01940},
issn = {1549-9596 (Print)},
journal = {J Chem Inf Model},
keywords = {& *Models, *Quantitative *Sequence A2A/antagonists Acid Adenosine Amino Binding Homology, Humans Ligands Molecular Pyrazoles Pyrimidines Relationship Sites Structure-Activity Triazoles inhibitors/*chemistry Receptor},
month = Feb,
note = {Michielan, Lisa Bacilieri, Magdalena Schiesaro, Andrea Bolcato, Chiara
Pastorin, Giorgia Spalluto, Giampiero Cacciari, Barbara Klotz, Karl
Norbet Kaseda, Chosei Moro, Stefano Research Support, Non-U.S. Gov't
United States Journal of chemical information and modeling J Chem
Inf Model. 2008 Feb;48(2):350-63. Epub 2008 Jan 24.},
number = 2,
pages = {350-63},
shorttitle = {Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based
homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine
antagonists binding site of the human adenosine A2A receptor},
timestamp = {2010-12-14T18:20:21.000+0100},
title = {Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based
homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine
antagonists binding site of the human adenosine A2A receptor},
url = {http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18215030},
volume = 48,
year = 2008
}